About
    Novo Group
    Leadership
    Responsibility
    Novo Nordisk Foundation
  • About
  • Investments
    Areas
    Life Science
    Seed InvestmentsVenture InvestmentsGrowth InvestmentsPrincipal InvestmentsPlanetary Health Investments
    Capital Investments
    Strategy
    Regions
    North AmericaEuropeAsia
    Portfolio
  • Investments
  • People
    Careers
    Open positions
  • People & Careers
  • News & Reports
    Facts & Figures
    Media Library
    Contact Public Relations
  • News & Reports

Steven Wang

Departments

Venture Investments, Novo Holdings US Inc.

Position

Vice President

Steven Wang joined Venture Investments (US) Inc. in 2022 as a senior associate in our Boston office. Steven previously worked in corporate development at Korro Bio, an early stage RNA editing company. Prior to Korro Bio, he was on the investing team at the Dementia Discovery fund, where he invested in early stage CNS companies.  Steven also spent time at L.E.K. consulting, where he worked with healthcare clients on strategy, M&A, and due diligence.

Steven holds a Ph.D. from Johns Hopkins, where he studied telomere biology, and a BA from the University of Pennsylvania.

Investing to benefit people and the planet

Novo Holdings A/S

Tuborg Havnevej 19

2900 Hellerup Denmark

+45 3527 6500

Email: Info@novoholdings.dk

CVR# 24257630

Media Relations

Christian Mostrup Scheel

Head of Public Relations

Email: novoholdingsmedia@novo.dk

+45 3067 4805

Novo Holdings US Inc.*

Boston:

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

San Francisco:

One Market Plaza, Floor 17 of the Steuart Tower

San Francisco, CA 94105 USA

+1 (415) 552-6686

Email: Info@novoholdings.dk

Novo Holdings Equity Asia Pte. Ltd.*

#40-01, 6 Battery Road

Singapore 049909

Email: Info@novoholdings.dk

Novo Holdings (UK office)

16 Berkeley Street

London W1J 8DZ

Email: Info@novoholdings.dk

Privacy noticeCode of ConductWhistleblowerArticles of association Policy on data ethicsElectronic invoicingDiversity policy

*Novo Ventures (US) Inc., Novo Holdings US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Follow us